Drawing for YOUR "OTHER" EHR

USPTO serial 90538776

YOUR "OTHER" EHR

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
PETTICAN, NATHANIEL VINCIENT
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with YOUR "OTHER" EHR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John C. McElwaine

John C. McElwaine NELSON MULLINS RILEY & SCARBOROUGH LLP301 SOUTH COLLEGE STREET, 23RD FLOOR IPCHARLOTTE, NC 28202UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Providing temporary use of online non-downloadable enterprise software for claims administration and management, evaluating patient safety, provider quality management, compliance management, and assessing enterprise risk for healthcare provider organizationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Nov 28, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 28, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 23, 2022ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Mar 25, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 23, 2022EX1GSOU EXTENSION 1 GRANTED—
Mar 23, 2022EXT1SOU EXTENSION 1 FILED—
Mar 23, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 19, 2022ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Oct 26, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 31, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 31, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 11, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 29, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 29, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Jul 29, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 29, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 29, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 28, 2021DOCKASSIGNED TO EXAMINER—
May 22, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 25, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance